As of Mar 30
| +3.24 / +7.58%|
The 8 analysts offering 12-month price forecasts for Hyperion Therapeutics Inc have a median target of 39.00, with a high estimate of 52.00 and a low estimate of 35.00. The median estimate represents a -15.18% decrease from the last price of 45.98.
The current consensus among 8 polled investment analysts is to Buy stock in Hyperion Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.